This Article Full Text Full Text (PDF) Data Supplement All Versions of this Article: 22/8/1299    most recent 01.ATV.0000026298.00663.58v1 Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kim, S. Articles by Iwao, H. Search for Related Content PubMed PubMed Citation Articles by Kim, S. Articles by Iwao, H. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB L-TYROSINE Related Collections ACE/Angiotension receptors Growth factors/cytokines Smooth muscle proliferation and differentiation Endothelium/vascular type/nitric oxide

(Arteriosclerosis, Thrombosis, and Vascular Biology. 2002;22:1299.)
© 2002 American Heart Association, Inc.

Vascular Biology

Beneficial Effects of Combined Blockade of ACE and AT₁ Receptor on Intimal Hyperplasia in Balloon-Injured Rat Artery

Shokei Kim; Yasukatsu Izumi; Yasuhiro Izumiya; Yumei Zhan; Masaru Taniguchi; Hiroshi Iwao

From the Department of Pharmacology, Osaka City University Medical School, Osaka, Japan.

Correspondence to Shokei Kim, MD, PhD, Department of Pharmacology, Osaka City University Medical School, 1-4-3 Asahimachi, Abeno-ku, Osaka 545-8585, Japan. E-mail kims{at}med.osaka-cu.ac.jp

Objective— The present study was undertaken to elucidate the effect of the ACE inhibitor and the angiotensin II type 1 (AT₁) receptor antagonist in combination on neointimal hyperplasia after balloon injury.

Methods and Results— Temocapril (an ACE inhibitor), CS-866 (an AT₁ receptor antagonist), or their combination was given orally to rats, and their effects were compared on vascular hyperplasia induced by balloon injury. The maximal preventive effect of temocapril and CS-866 alone on neointimal thickening after balloon injury was obtained at a dose of 20 and 10 mg/kg per day, respectively. However, compared with either agent alone, combined temocapril and CS-866 (20 and 10 mg/kg per day, respectively) prevented intimal thickening to a larger extent. Furthermore, compared with either agent alone, combined temocapril and CS-866 prevented vascular smooth muscle cell proliferation in the intima more potently. The increase in platelet-derived growth factor receptor tyrosyl phosphorylation was reduced more potently by the combination of both agents compared with either agent alone. The nonpeptide bradykinin B₂ receptor antagonist or the NO synthase inhibitor reduced the prevention of intimal thickening by combined temocapril and CS-866.

Conclusions— Compared with either agent alone, the combination of an ACE inhibitor and an AT₁ receptor antagonist is more effective in the prevention of vascular hyperplasia due to bradykinin or NO.

Key Words: balloon injury • intimal thickening • angiotensin • angiotensin-converting enzyme • combination therapy

This article has been cited by other articles:

				M. Azizi and J. Menard Combined Blockade of the Renin-Angiotensin System With Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Type 1 Receptor Antagonists Circulation, June 1, 2004; 109(21): 2492 - 2499. [Full Text] [PDF]

				B. Jiang, S. Xu, X. Hou, D. R. Pimentel, and R. A. Cohen Angiotensin II Differentially Regulates Interleukin-1-{beta}-inducible NO Synthase (iNOS) and Vascular Cell Adhesion Molecule-1 (VCAM-1) Expression: ROLE OF p38 MAPK J. Biol. Chem., May 7, 2004; 279(19): 20363 - 20368. [Abstract] [Full Text] [PDF]